Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
News | October 1, 2019
Contact an expert at Devyser
If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.
Devyser advances U.S. clinical strategy with first patient enrolled in Devyser Accept cfDNA study
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Devyser CFTR achieves IVDR compliance, strengthening clinical confidence in cystic fibrosis diagnostics
Devyser, a pioneer in advanced genetic testing solutions, is pleased to announce that its...
.png)
Devyser launches Genomic Blood Typing assay
Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation...